Revumenib
Syndax Pharma
['bet', 'revumenib', 'leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'augment-101', 'augment,study']
 continues to share updates on the outcomes of treatment with revumenib. this time on the durable responses post allo-sct in kmt2ar and mnpm1 r/r #aml, highlighting select patients who received revumenib as maintenance therapy post allo-sct
#ash22, #leusm, #amlsm 
Research scholar @MDAndersonnews Leukemia Department| MD '21 @AUB_Lebanon | My tweets are my own | RTs are not endorsements